2,4-thiazolidinedione has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HF | 1 |
| Guo, LQ | 1 |
| Huang, YY | 1 |
| Chen, K | 1 |
| Tao, JL | 1 |
| Li, SM | 1 |
| Chen, XW | 1 |
1 other study available for 2,4-thiazolidinedione and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection.
Topics: Animals; Doxorubicin; Glomerulosclerosis, Focal Segmental; Kidney Diseases; Male; Podocytes; Protein | 2010 |